Obama’s immigration actions: An overview
Some of the changes represent a sharp break from past practices, but others probably should have been made a long time ago
Author: Randall A. Drew
More news from NHBR:
Howard Brodsky brings cooperative business perspective to United Nations Commission
Howard Brodsky, co-founder and chairman of CCA Global Partners (CCA), highlighted the power of cooperatives (co-ops) — shared business models owned and governed by their members — as the “great economic equalizer” for small businesses worldwide in his remarks at the United Nation’s (UN) annual Session of the Commission for Social Development at UN headquarters in New York City. This session convened global business leaders and innovators to discuss advancing social development and social justice through coordinated, equitable and inclusive policies.
The NH economy is ‘stable, moderating’ — if you can believe ChatGPT
Where does AI end and your ‘secret sauce’ begin?
Q&A with Director and CEO, Currier Museum of Art Jordana Pomeroy
Jordana Pomeroy’s path to New Hampshire included stops in much bigger locales, but when the board of the Currier Museum of Art contacted her to consider leaving South Florida to come to Manchester, it was the right move at the right time.
Newport’s largest employer, Sturm, Ruger & Co., confirms job cuts
Firearms manufacturer Sturm, Ruger & Co., confirmed earlier this month that it had reduced its force.
Energy officials fight Eversource rates in court
New Hampshire’s energy officials are asking the state’s Supreme Court to review a decision by utility regulators that raised rates for Eversource customers last summer.
Funding cuts have hurt outdoor industry, advocates say
Goodlander says ‘raising hell’ best strategy to secure promised federal dollars
State got a one-time shot. Now what?
Analysts fear overall revenue will lag unless other accounts pick up the pace
Housing gains
NH has added 25,688 housing units since 2020, state says
NH company shines light on UV therapy for autoimmune conditions
Started in 2021, Cytokind describes itself as 'the global leader in using UVB light to treat immune disorders and improve survival and the quality of life for patients'
